| USD ($) $ in Millions | Sep 3, 2026 | Aug 28, 2025 | Aug 29, 2024 | Aug 31, 2023 | Sep 1, 2022 | Sep 2, 2021 | Sep 3, 2020 | Aug 29, 2019 | Aug 30, 2018 | Aug 31, 2017 | Sep 1, 2016 | Sep 3, 2015 | Aug 28, 2014 | Aug 29, 2013 | Aug 30, 2012 | Sep 1, 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash flows from operating activities | ||||||||||||||||
Net income | $ 84,969 | $ 8,539 | $ 778 | |||||||||||||
Net income | - | - | - | |||||||||||||
Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||||||
Depreciation expense and amortization of intangible assets | 9,503 | 8,352 | 7,780 | |||||||||||||
Stock-based compensation | 1,333 | 972 | 833 | |||||||||||||
Provision to write down inventories to net realizable value | - | 0 | 0 | |||||||||||||
Goodwill impairment | - | 0 | 0 | |||||||||||||
Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||||||
Amortization of debt discount and other costs | - | - | - | |||||||||||||
Restructure and asset impairments | - | - | - | |||||||||||||
Loss on debt repurchases and conversions | - | - | - | |||||||||||||
Gain on remeasurement of previously-held equity interest in Inotera | - | - | - | |||||||||||||
(Gain) loss from currency hedges, net | - | - | - | |||||||||||||
Adjustment to gain on MMJ Acquisition | - | - | - | |||||||||||||
Equity in net (income) loss of equity method investees | - | - | - | |||||||||||||
Gain from Inotera issuance of shares | - | - | - | |||||||||||||
Gain from disposition of interest in Aptina | - | - | - | |||||||||||||
Gain from disposition of Japan Fab | - | - | - | |||||||||||||
Restructure charges (credits) | - | - | - | |||||||||||||
(Gain) loss from disposition of property, plant and equipment | - | - | - | |||||||||||||
Gain from acquisition of Elpida | - | - | - | |||||||||||||
Change in operating assets and liabilities: | ||||||||||||||||
Receivables | (25,206) | (1,776) | (3,581) | |||||||||||||
Inventories | (2,017) | 520 | (488) | |||||||||||||
Accounts payable and accrued expenses | 8,707 | 862 | 1,915 | |||||||||||||
Other current liabilities | 3,141 | (272) | 989 | |||||||||||||
Other noncurrent liabilities | 9,633 | - | - | |||||||||||||
Payments attributed to intercompany balances with Inotera | - | - | - | |||||||||||||
Deferred income taxes, net | - | - | - | |||||||||||||
Customer prepayments | - | - | - | |||||||||||||
Deferred income | - | - | - | |||||||||||||
Other | (388) | 328 | 281 | |||||||||||||
Net cash provided by operating activities | 89,675 | 17,525 | 8,507 | |||||||||||||
Cash flows from investing activities | ||||||||||||||||
Purchases of available-for-sale securities | (34,871) | (1,890) | (1,999) | |||||||||||||
Expenditures for property, plant, and equipment | (30,712) | (15,857) | (8,386) | |||||||||||||
Purchases of non-marketable equity securities | (1,046) | - | - | |||||||||||||
Payments to settle hedging activities | - | - | - | |||||||||||||
Acquisition of Inotera | - | - | - | |||||||||||||
Proceeds from maturities of available-for-sale securities | - | - | - | |||||||||||||
Proceeds from government incentives | 3,316 | 2,005 | 315 | |||||||||||||
(Increase) decrease in restricted cash | - | - | - | |||||||||||||
Acquisition of noncontrolling interests in TECH | - | - | - | |||||||||||||
Additions to equity method investments | - | - | - | |||||||||||||
Proceeds from maturities and sales of available-for-sale securities | 1,988 | 1,698 | 1,794 | |||||||||||||
Proceeds from sales of available-for-sale securities | - | - | - | |||||||||||||
Proceeds from sale of Lehi, Utah fab | - | - | 0 | |||||||||||||
Cash acquired from acquisition of Elpida, net of cash paid | - | - | - | |||||||||||||
Proceeds from sales of property, plant and equipment | - | - | - | |||||||||||||
Proceeds from settlement of hedging activities | - | - | - | |||||||||||||
Return of equity method investment | - | - | - | |||||||||||||
Cash received from disposition of interest in Aptina | - | - | - | |||||||||||||
Cash acquired from acquisition of Numonyx | - | - | - | |||||||||||||
Other | (316) | (43) | (33) | |||||||||||||
Net cash used for investing activities | (61,641) | (14,087) | (8,309) | |||||||||||||
Cash flows from financing activities | ||||||||||||||||
Proceeds from customer contract liability deposits | 12,747 | - | - | |||||||||||||
Repayments of debt | (10,043) | (4,619) | (1,897) | |||||||||||||
Payments on equipment purchase contracts | - | 0 | (149) | |||||||||||||
Acquisition of noncontrolling interest in IMFT | - | - | - | |||||||||||||
Cash paid for capped call transactions | - | - | - | |||||||||||||
Distributions to noncontrolling interests | - | - | - | |||||||||||||
Proceeds from issuance of debt | 0 | 4,430 | 999 | |||||||||||||
Proceeds from equipment sale-leaseback transactions | - | - | - | |||||||||||||
Proceeds from issuance of common stock | - | - | - | |||||||||||||
Contributions from noncontrolling interests | - | - | - | |||||||||||||
Repurchases of common stock - withholdings on employee equity awards | (1,127) | - | - | |||||||||||||
Repurchases of common stock - repurchase program | (650) | 0 | (300) | |||||||||||||
Payments of dividends to shareholders | (610) | (522) | (513) | |||||||||||||
Proceeds from issuance of stock | - | - | - | |||||||||||||
Proceeds from issuance of stock under equity plans | - | - | - | |||||||||||||
Other | 313 | (139) | 18 | |||||||||||||
Net cash provided by (used for) financing activities | 630 | (850) | (1,842) | |||||||||||||
Effect of changes in currency exchange rates on cash, cash equivalents, and restricted cash | 81 | 6 | 40 | |||||||||||||
Net increase (decrease) in cash, cash equivalents, and restricted cash | 28,745 | 2,594 | (1,604) | |||||||||||||
Effect of changes in currency exchange rates on cash and equivalents | - | - | - | |||||||||||||
Net increase (decrease) in cash and equivalents | - | - | - | |||||||||||||
Supplemental disclosures | ||||||||||||||||
Income taxes paid, net | (1,254) | (583) | (338) | |||||||||||||
Interest paid, net of amounts capitalized | (197) | (418) | (503) | |||||||||||||
Noncash investing and financing activities | ||||||||||||||||
Exchange of convertible notes | - | - | - | |||||||||||||
Stock and restricted stock units issued in acquisition of Numonyx | - | - | - | |||||||||||||
Acquisition of interest in Transform | - | - | - | |||||||||||||
Acquisition of noncontrolling interest | - | - | - | |||||||||||||
Conversion of notes to stock, net of unamortized issuance cost | - | - | - | |||||||||||||
Noncash equipment acquisitions on contracts payable and finance leases | - | - | - | |||||||||||||
Noncash equipment acquisitions on contracts payable | - | - | 118 | |||||||||||||
Noncash investing and financing activity | ||||||||||||||||
Non-cash equipment acquisitions on contracts payable | - | 321 | - | |||||||||||||
Non-cash acquisitions of finance lease right-of-use assets | $ 143 | - | - |